These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 31297564)
1. Stylosin and some of its synthetic derivatives induce apoptosis in prostate cancer cells as 15-lipoxygenase enzyme inhibitors. Goftari SN; Sadeghian H; Bahrami AR; Maleki F; Matin MM Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1491-1502. PubMed ID: 31297564 [TBL] [Abstract][Full Text] [Related]
2. Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells. Maleki F; Sadeghian H; Bahrami AR; Goftari SN; Matin MM Anticancer Agents Med Chem; 2023; 23(15):1722-1730. PubMed ID: 37171011 [TBL] [Abstract][Full Text] [Related]
3. 8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity. Hosseinymehr M; Matin MM; Sadeghian H; Bahrami AR; Kaseb-Mojaver N Anticancer Drugs; 2016 Oct; 27(9):854-62. PubMed ID: 27362790 [TBL] [Abstract][Full Text] [Related]
4. 7-Farnesyloxycoumarin Exerts Anti-cancer Effects on a Prostate Cancer Cell Line by 15-LOX-1 Inhibition. Saboormaleki S; Sadeghian H; Bahrami AR; Orafaie A; Matin MM Arch Iran Med; 2018 Jun; 21(6):251-259. PubMed ID: 29940744 [TBL] [Abstract][Full Text] [Related]
5. 8-Geranyloxycarbostyril as a potent 15-LOX-1 inhibitor showed great anti-tumor effects against prostate cancer. Aghasizadeh M; Moghaddam T; Bahrami AR; Sadeghian H; Alavi SJ; Matin MM Life Sci; 2022 Mar; 293():120272. PubMed ID: 35065164 [TBL] [Abstract][Full Text] [Related]
6. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon. Sarveswaran S; Thamilselvan V; Brodie C; Ghosh J Biochim Biophys Acta; 2011 Dec; 1813(12):2108-17. PubMed ID: 21824498 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells. Sarveswaran S; Chakraborty D; Chitale D; Sears R; Ghosh J J Biol Chem; 2015 Feb; 290(8):4994-5006. PubMed ID: 25540201 [TBL] [Abstract][Full Text] [Related]
9. [Selective 12-lipoxygenase inhibition potentiates the effect of radiation on human prostate cancer cells in vitro and in vivo]. Lövey J; Nie D; Tóvári J; Kenessey I; Kandouz M; Tímár J; Kásler M; Honn KV Magy Onkol; 2014 Sep; 58(3):211-8. PubMed ID: 25260086 [TBL] [Abstract][Full Text] [Related]
10. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies. Li L; Zhu Z; Joshi B; Porter AT; Tang DG Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524 [TBL] [Abstract][Full Text] [Related]
12. Zyflamend-mediated inhibition of human prostate cancer PC3 cell proliferation: effects on 12-LOX and Rb protein phosphorylation. Yang P; Cartwright C; Chan D; Vijjeswarapu M; Ding J; Newman RA Cancer Biol Ther; 2007 Feb; 6(2):228-36. PubMed ID: 17218785 [TBL] [Abstract][Full Text] [Related]
13. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Hoque A; Lippman SM; Wu TT; Xu Y; Liang ZD; Swisher S; Zhang H; Cao L; Ajani JA; Xu XC Carcinogenesis; 2005 Apr; 26(4):785-91. PubMed ID: 15661803 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer. Tang Y; Wang MT; Chen Y; Yang D; Che M; Honn KV; Akers GD; Johnson SR; Nie D Int J Cancer; 2009 Apr; 124(7):1545-51. PubMed ID: 19089921 [TBL] [Abstract][Full Text] [Related]
15. Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells. Kandouz M; Nie D; Pidgeon GP; Krishnamoorthy S; Maddipati KR; Honn KV Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):189-204. PubMed ID: 14518561 [TBL] [Abstract][Full Text] [Related]
16. The importance of 15-lipoxygenase inhibitors in cancer treatment. Orafaie A; Matin MM; Sadeghian H Cancer Metastasis Rev; 2018 Sep; 37(2-3):397-408. PubMed ID: 29882120 [TBL] [Abstract][Full Text] [Related]
17. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy. Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042 [TBL] [Abstract][Full Text] [Related]
18. Lipoxygenase inhibitors prevent urological cancer cell growth. Matsuyama M; Yoshimura R; Tsuchida K; Takemoto Y; Segawa Y; Shinnka T; Kawahito Y; Sano H; Nakatani T Int J Mol Med; 2004 May; 13(5):665-8. PubMed ID: 15067367 [TBL] [Abstract][Full Text] [Related]
19. Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells. Jankun J; Aleem AM; Malgorzewicz S; Szkudlarek M; Zavodszky MI; Dewitt DL; Feig M; Selman SH; Skrzypczak-Jankun E Mol Cancer Ther; 2006 May; 5(5):1371-82. PubMed ID: 16731771 [TBL] [Abstract][Full Text] [Related]
20. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway. Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]